Skip to content

Randomized Controlled Trial of Mindfulness Meditation for Generalized Anxiety Disorder: Effects on Anxiety and Stress Reactivity

Elizabeth A Hoge, Eric Bui, L. Marques, Christina A. Metcalf, Laura K. Morris, D. Robinaugh, John J. Worthington, Mark H Pollack, N. Simon

The Journal of Clinical Psychiatry March 13, 2013 DOI: 10.4088/jcp.12m08083 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 93
Population Adults with DSM-IV-diagnosed generalized anxiety disorder
Interventions Mindfulness-Based Stress Reduction (MBSR) Stress Management Education (SME)
Duration 8-week group intervention
Measures Hamilton Anxiety Scale (HAM-A), Clinical Global Impression of Severity (CGI-S), Clinical Global Impression of Improvement (CGI-I), Beck Anxiety Inventory (BAI), Trier Social Stress Test (TSST)
Topics Anxiety Meditation
Key findings Both MBSR and an active control (SME) significantly reduced Hamilton Anxiety Scale scores after 8 weeks, with no significant difference between groups. However, MBSR was associated with greater improvement on the CGI-S, CGI-I, and Beck Anxiety Inventory (all Ps<0.05), greater reductions in anxiety and distress during the Trier Social Stress Test (P<0.05), and a larger increase in positive self-statements (P=0.004). The authors suggest MBSR may improve anxiety symptoms and stress reactivity in generalized anxiety disorder.

Abstract

Objective: Mindfulness meditation has met increasing interest as a therapeutic strategy for anxiety disorders, but prior studies have been limited by methodological concerns, including a lack of an active comparison group. This is the first randomized, controlled trial comparing the manualized Mindfulness-Based Stress Reduction (MBSR) program with an active control for Generalized Anxiety Disorder, a disorder characterized by chronic worry and physiological hyperarousal symptoms.

Method: Ninety-three individuals with DSM-IV-diagnosed GAD were randomized to an 8-week group intervention with MBSR or to an attention control, Stress Management Education (SME) between 2009 and 2011. Anxiety symptoms were measured with the Hamilton Anxiety Scale (HAM-A, primary outcome measure), the Clinical Global Impression of Severity and Improvement (CGI-S and CGI-I), and the Beck Anxiety Inventory (BAI). Stress reactivity was assessed by comparing anxiety and distress during pre- and post-treatment Trier Social Stress Tests (TSST).

Results: A modified intent-to-treat analysis including participants who completed at least one session of MBSR (N=48) or SME (N=41) showed that both interventions led to significant reductions in HAM-A scores at endpoint, but did not significantly differ. MBSR, however, was associated with a significantly greater reduction in anxiety as measured by the CGI-S, the CGI-I, and the BAI (all Ps<0.05). MBSR was also associated with greater reductions than SME in anxiety and distress ratings in response to the TSST stress challenge (P<0.05), and a greater increase in positive self-statements (P=0.004).

Conclusions: These results suggest that MBSR may have a beneficial effect on anxiety symptoms in GAD, and may also improve stress reactivity and coping as measured in a laboratory stress challenge.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics